Among the oncogenes, MUC16 (mutated in 18.9% of tumours), PIK3CA (12.4%), and KRAS (11.1%) were the most frequently mutated across the profiled samples (Fig. 2a). The gene discussed is PIK3CA; the disease is neoplasm.